GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Shiller PE Ratio

Mega Lifesciences PCL (BKK:MEGA-R) Shiller PE Ratio : 13.46 (As of Jul. 23, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Shiller PE Ratio?

As of today (2025-07-23), Mega Lifesciences PCL's current share price is ฿28.26507. Mega Lifesciences PCL's E10 for the quarter that ended in Mar. 2025 was ฿2.10. Mega Lifesciences PCL's Shiller PE Ratio for today is 13.46.

The historical rank and industry rank for Mega Lifesciences PCL's Shiller PE Ratio or its related term are showing as below:

BKK:MEGA-R' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.63   Med: 24.69   Max: 42.72
Current: 14.26

During the past years, Mega Lifesciences PCL's highest Shiller PE Ratio was 42.72. The lowest was 12.63. And the median was 24.69.

BKK:MEGA-R's Shiller PE Ratio is ranked better than
80.19% of 525 companies
in the Drug Manufacturers industry
Industry Median: 27.76 vs BKK:MEGA-R: 14.26

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mega Lifesciences PCL's adjusted earnings per share data for the three months ended in Mar. 2025 was ฿0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ฿2.10 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mega Lifesciences PCL Shiller PE Ratio Historical Data

The historical data trend for Mega Lifesciences PCL's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Shiller PE Ratio Chart

Mega Lifesciences PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 38.43 30.10 23.36 17.32

Mega Lifesciences PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.33 20.68 20.84 17.32 14.77

Competitive Comparison of Mega Lifesciences PCL's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Mega Lifesciences PCL's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mega Lifesciences PCL's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mega Lifesciences PCL's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mega Lifesciences PCL's Shiller PE Ratio falls into.


;
;

Mega Lifesciences PCL Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mega Lifesciences PCL's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=28.26507/2.10
=13.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mega Lifesciences PCL's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Mega Lifesciences PCL's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.52/134.9266*134.9266
=0.520

Current CPI (Mar. 2025) = 134.9266.

Mega Lifesciences PCL Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.190 100.684 0.255
201509 0.180 100.392 0.242
201512 0.310 99.792 0.419
201603 0.130 100.470 0.175
201606 0.250 101.688 0.332
201609 0.190 101.861 0.252
201612 0.340 101.863 0.450
201703 0.220 102.862 0.289
201706 0.330 103.349 0.431
201709 0.280 104.136 0.363
201712 0.440 104.011 0.571
201803 0.300 105.290 0.384
201806 0.330 106.317 0.419
201809 0.290 106.507 0.367
201812 0.470 105.998 0.598
201903 0.290 107.251 0.365
201906 0.250 108.070 0.312
201909 0.320 108.329 0.399
201912 0.438 108.420 0.545
202003 0.370 108.902 0.458
202006 0.350 108.767 0.434
202009 0.390 109.815 0.479
202012 0.490 109.897 0.602
202103 0.380 111.754 0.459
202106 0.580 114.631 0.683
202109 0.700 115.734 0.816
202112 0.569 117.630 0.653
202203 0.700 121.301 0.779
202206 0.650 125.017 0.702
202209 0.760 125.227 0.819
202212 0.459 125.222 0.495
202303 0.520 127.348 0.551
202306 0.610 128.729 0.639
202309 0.610 129.860 0.634
202312 0.543 129.419 0.566
202403 0.550 131.776 0.563
202406 0.590 132.554 0.601
202409 0.440 133.029 0.446
202412 0.733 133.157 0.743
202503 0.520 134.927 0.520

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mega Lifesciences PCL  (BKK:MEGA-R) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mega Lifesciences PCL Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mega Lifesciences PCL Business Description

Traded in Other Exchanges
Address
Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260
Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines